Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuaibing Liu

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Advanced Healthcare Materials|August 10, 2022
Monoporous Microsphere as a Dynamically Movable Drug Carrier for Osteoporotic Bone RemodelingYawu Li, Yao Zha, Weikang Hu, et al.
European Journal of Clinical Pharmacology|February 15, 2018
Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjectsShuaibing Liu, Ling Xue, Xiangfen Shi, et al.
Frontiers in Pharmacology|November 1, 2021
Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated MetaboliteShuaibing Liu, Lei Hou, Cai Li, et al.
Biochemical Pharmacology|September 15, 2025
The regulatory roles of pparα on hepatic drug-metabolizing enzymes in primary sclerosing cholangitis Syrian hamstersShuaibing Liu, Jinxin Miao, Hang Li, et al.
Journal of Clinical Pharmacology|April 24, 2024
Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese SubjectsShuaibing Liu, Xia Yao, Jun Tao, et al.
Acta Biomaterialia|January 18, 2022
Integrated polycaprolactone microsphere-based scaffolds with biomimetic hierarchy and tunable vascularization for osteochondral repairXiang Gu, Yao Zha, Yawu Li, et al.
Neoplasia (New York, N.Y.)|June 12, 2026
Tumor cell-intrinsic NSUN2 deficiency reprograms macrophages to sensitize non-small cell lung cancer to EGFR inhibitors by reversing immune evasionYueqin Wang, Jingyao Wei, Wenbin Xu, et al.
Scientific Reports|October 28, 2016
Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agentsLichuan Wu, Guizhen Wang, Shuaibing Liu, et al.
ACS Nano|October 15, 2024
Lymphocyte-Derived Engineered Apoptotic Bodies with Inflammation Regulation and Cartilage Affinity for Osteoarthritis TherapyJia Chen, Zihao Wang, Shuaibing Liu, et al.
Biochemical Pharmacology|June 24, 2024
Identification of the human Cytochrome P450 enzymes (P450s) responsible for metabolizing infigratinib to its pharmacologically active Metabolites, BHS697, and CQM157, and assessment of their in vitro inhibition of P450s and UDP-glucuronosyltransferases (UGTs)Shuaibing Liu, Shiyu Zhao, XueXia Zhang, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Advanced Healthcare Materials|August 10, 2022
Monoporous Microsphere as a Dynamically Movable Drug Carrier for Osteoporotic Bone RemodelingYawu Li, Yao Zha, Weikang Hu, et al.
European Journal of Clinical Pharmacology|February 15, 2018
Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjectsShuaibing Liu, Ling Xue, Xiangfen Shi, et al.
Frontiers in Pharmacology|November 1, 2021
Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated MetaboliteShuaibing Liu, Lei Hou, Cai Li, et al.
Biochemical Pharmacology|September 15, 2025
The regulatory roles of pparα on hepatic drug-metabolizing enzymes in primary sclerosing cholangitis Syrian hamstersShuaibing Liu, Jinxin Miao, Hang Li, et al.
Journal of Clinical Pharmacology|April 24, 2024
Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese SubjectsShuaibing Liu, Xia Yao, Jun Tao, et al.
Acta Biomaterialia|January 18, 2022
Integrated polycaprolactone microsphere-based scaffolds with biomimetic hierarchy and tunable vascularization for osteochondral repairXiang Gu, Yao Zha, Yawu Li, et al.
Neoplasia (New York, N.Y.)|June 12, 2026
Tumor cell-intrinsic NSUN2 deficiency reprograms macrophages to sensitize non-small cell lung cancer to EGFR inhibitors by reversing immune evasionYueqin Wang, Jingyao Wei, Wenbin Xu, et al.
Scientific Reports|October 28, 2016
Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agentsLichuan Wu, Guizhen Wang, Shuaibing Liu, et al.
ACS Nano|October 15, 2024
Lymphocyte-Derived Engineered Apoptotic Bodies with Inflammation Regulation and Cartilage Affinity for Osteoarthritis TherapyJia Chen, Zihao Wang, Shuaibing Liu, et al.
Biochemical Pharmacology|June 24, 2024
Identification of the human Cytochrome P450 enzymes (P450s) responsible for metabolizing infigratinib to its pharmacologically active Metabolites, BHS697, and CQM157, and assessment of their in vitro inhibition of P450s and UDP-glucuronosyltransferases (UGTs)Shuaibing Liu, Shiyu Zhao, XueXia Zhang, et al.
Pageof 5